Inspire Medical Systems, Inc. (INSP) is a publicly traded Healthcare sector company. As of May 21, 2026, INSP trades at $43.99 with a market cap of $1.21B and a P/E ratio of 9.83. INSP moved +3.76% today. Year to date, INSP is -53.42%; over the trailing twelve months it is -70.58%. Its 52-week range spans $39.61 to $216.01. Analyst consensus is neutral with an average price target of $54.36. Rallies surfaces INSP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Inspire Medical Systems Downgraded Despite $204.5M Q1 Revenue and $0.10 EPS: Piper Sandler cut its rating on Inspire Medical Systems from Overweight to Neutral despite the company reporting adjusted EPS of $0.10 and over $204.5 million in Q1 revenue, marking 1.6% year-on-year growth. The quarter also delivered $12.8 million in operating cash flow as management emphasized disciplined cost control and revenue growth.
| Metric | Value |
|---|---|
| Price | $43.99 |
| Market Cap | $1.21B |
| P/E Ratio | 9.83 |
| EPS | $4.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $216.01 |
| 52-Week Low | $39.61 |
| Volume | 926 |
| Avg Volume | 0 |
| Revenue (TTM) | $915.25M |
| Net Income | $131.14M |
| Gross Margin | 85.78% |
13 analysts cover INSP: 0 strong buy, 3 buy, 10 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $54.36.